Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Update

13 Nov 2017 07:00

RNS Number : 2382W
Kingspan Group PLC
13 November 2017
 

Kingspan Group Plc

Trading Update

 

13 November 2017

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues a Trading Update, with trading information for the period to 30 September 2017.

Sales in the nine month period to 30 September were €2.69bn, up 19% on the same period in the prior year (+21% pre currency). Sales in the third quarter were up 17% (+20% pre currency). Underlying sales, pre currency and acquisitions, were up 11% in the year to date and were up 13% in the third quarter.

Insulated Panel sales in the first nine months increased by 16% (+18% pre currency), and increased by 13% (+15% pre currency) in the third quarter. Underlying sales were 12% ahead both year to date and in the third quarter, owing significantly to the pass-through of input related inflation. Mainland European sales were solid in most markets and notably positive in France. In the UK we have experienced a sense of near-term indecision around order placement, however our future activity tracker remains modestly ahead of prior year. North America sales were solid overall, and in Latin America we have experienced very encouraging activity since taking a position there in recent months.

Insulation Board sales in the first nine months were up 10% (+13% pre currency) and were up by 16% in quarter three (+19% pre currency). Underlying sales growth was 13% year to date and 19% in the third quarter. Sales growth year on year reflected strong price growth necessitated by raw material inflation. In addition Kooltherm® volume continued to outgrow our other insulation materials, and was particularly positive in the UK, Ireland, Western Europe and the Nordics. The North America and Australasia markets are still in a developmental phase for Kingspan as we are still in the early days of generating demand for high performance insulation in these markets.

 

Light & Air sales both year to date and in the third quarter are strongly ahead reflecting year on year acquisition activity. Underlying sales year to date grew by 4% and by 7% in the third quarter. As we exit 2017 the annualised sales of this division will be in the region of €220m.

Environmental sales in the first nine months were up 12% (+17% pre currency) and were up 11% (+14% pre currency) in the third quarter. A particular highlight was the ongoing growth in rainwater harvesting in Australia. UK and Europe sales were solid overall, and margins continue to progress upwards.

Access Floors sales in the first nine months increased by 2% (+5% pre currency) and were up 4% (+9% pre currency) in the third quarter. UK office activity is softening, as expected, with the US office market remaining relatively flat. Datacentre activity across the division was encouraging as was the continued growth in sales of our broader product portfolio into that segment.

 

Net debt at the end of September 2016 was €479.8m. Net debt at year end is forecast to be in the region of €400m.

 

On the back of significant input inflation in the third quarter, and our associated price inflation, we anticipate this trend to remain through the fourth quarter albeit less pronounced as chemical cost increases reach their peak. In general our end markets are relatively stable, notwithstanding some recent evidence of a slowdown in UK commercial and industrial activity. Separately, the Group's development pipeline is encouraging.

 

Assuming current exchange rates prevail and conscious that much of the seasonally variable fourth quarter remains, we expect to deliver full year trading profit growth of approximately 10% or c. €375m.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKKDBOBDDADD
Date   Source Headline
7th Mar 20173:57 pmRNSAnnual Financial Report
6th Mar 20177:00 amRNSMain Securities Market Notice
1st Mar 20175:38 pmRNSDirector/PDMR Shareholding
1st Mar 20179:49 amRNSDirector/PDMR Shareholding
1st Mar 20179:30 amRNSTotal Voting Rights
27th Feb 20174:32 pmRNSDirector/PDMR Shareholding
23rd Feb 201710:20 amRNSBlock Listing Application
22nd Feb 20173:04 pmRNSDirector/PDMR Shareholding
20th Feb 20174:36 pmRNSDirector/PDMR Shareholding
20th Feb 201712:32 pmRNSDirector/PDMR Shareholding
17th Feb 20171:51 pmRNSHolding(s) in Company
17th Feb 20177:00 amRNSFinal Results
24th Jan 201712:04 pmRNSNotice of Results
18th Jan 201711:19 amRNSHolding(s) in Company
3rd Jan 20179:45 amRNSHolding(s) in Company
3rd Jan 20179:30 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSTotal Voting Rights
14th Dec 20165:02 pmRNSHolding(s) in Company
12th Dec 20164:09 pmRNSHolding(s) in Company
1st Dec 20162:28 pmRNSTotal Voting Rights
29th Nov 20162:30 pmRNSHolding(s) in Company
23rd Nov 20165:04 pmRNSHolding(s) in Company
21st Nov 20162:33 pmRNSDirector/PDMR Shareholding
16th Nov 20165:07 pmRNSCompletion of US private placement
16th Nov 20162:44 pmRNSHolding(s) in Company
14th Nov 20167:00 amRNSTrading Update
10th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 201611:08 amRNSHolding(s) in Company
1st Nov 20161:15 pmRNSTotal Voting Rights
21st Oct 201612:46 pmRNSHolding(s) in Company
3rd Oct 20161:27 pmRNSTotal Voting Rights
26th Sep 201610:01 amRNSHolding(s) in Company
1st Sep 20163:39 pmRNSDirector/PDMR Shareholding
1st Sep 201611:00 amRNSTotal Voting Rights
25th Aug 20164:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20167:00 amRNSHalf-year Report
2nd Aug 201610:10 amRNSHolding(s) in Company
27th Jul 20165:39 pmRNSHolding(s) in Company
25th Jul 20165:09 pmRNSHolding(s) in Company
14th Jul 20162:18 pmRNSHolding(s) in Company
1st Jul 20164:43 pmRNSHolding(s) in Company
1st Jul 20169:15 amRNSBlock listing Interim Review
1st Jul 20169:00 amRNSTotal Voting Rights
28th Jun 201610:21 amRNSHolding(s) in Company
10th Jun 20163:15 pmRNSHolding(s) in Company
1st Jun 20169:57 amRNSTotal Voting Rights
24th May 20165:02 pmRNSDirector/PDMR Shareholding
20th May 20164:28 pmRNSDirector/PDMR Shareholding
19th May 20164:25 pmRNSDirector/PDMR Shareholding
12th May 20162:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.